|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/10/13 Biolase, Inc 10-Q 3/31/13 61:3.9M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 313K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 19K
40: R1 Document and Entity Information HTML 40K
30: R2 Consolidated Balance Sheets HTML 135K
38: R3 Consolidated Balance Sheets (Parenthetical) HTML 47K
42: R4 Consolidated Statements Of Operations And HTML 102K
Comprehensive Loss
55: R5 Consolidated Statements Of Cash Flows HTML 128K
32: R6 Basis of Presentation HTML 35K
37: R7 Recent Accounting Pronouncements HTML 27K
27: R8 Stock-Based Awards and Per Share Information HTML 60K
19: R9 Inventory HTML 26K
57: R10 Property, Plant, and Equipment HTML 32K
44: R11 Intangible Assets and Goodwill HTML 46K
43: R12 Accrued Liabilities and Deferred Revenue HTML 43K
48: R13 Lines Of Credit and Other Borrowings HTML 27K
49: R14 Commitments and Contingencies HTML 30K
47: R15 Segment Information HTML 32K
50: R16 Concentrations HTML 21K
39: R17 Income Taxes HTML 30K
41: R18 Subsequent Events HTML 24K
46: R19 Accounting Policies (Policies) HTML 89K
61: R20 Stock-Based Awards and Per Share Information HTML 59K
(Tables)
52: R21 Inventory (Tables) HTML 24K
34: R22 Property, Plant, and Equipment (Tables) HTML 30K
45: R23 Intangible Assets and Goodwill (Tables) HTML 40K
36: R24 Accrued Liabilities and Deferred Revenue (Tables) HTML 48K
15: R25 Segment Information (Tables) HTML 25K
53: R26 Basis of Presentation - Additional Information HTML 44K
(Detail)
58: R27 Stock Based Awards and Per Share Information - HTML 74K
Additional Information (Detail)
23: R28 Classification of Compensation Expense Associated HTML 27K
with Share-Based Payments (Detail)
22: R29 Assumptions Used in Estimating Fair Value of Stock HTML 30K
Options Granted (Detail)
25: R30 Summary of Option Activity (Detail) HTML 71K
26: R31 Cash Proceeds Along with Fair Value Disclosures HTML 37K
Related to grants Exercises and Vesting Options
(Detail)
28: R32 Components of Inventory (Detail) HTML 31K
14: R33 Inventory - Additional Information (Detail) HTML 24K
51: R34 Summary of Property, Plant, and Equipment (Detail) HTML 36K
33: R35 Property, Plant, and Equipment - Additional HTML 21K
Information (Detail)
35: R36 Intangible Assets and Goodwill - Additional HTML 22K
Information (Detail)
17: R37 Intangible Assets Related to Accumulated HTML 51K
Amortization and Goodwill (Detail)
60: R38 Components of Accrued Liabilities (Detail) HTML 43K
12: R39 Changes In Initial Product Warranty Accrual and HTML 37K
Expenses Under Initial and Extended Warranties
(Detail)
29: R40 Summary of Deferred Revenue (Detail) HTML 37K
54: R41 Lines of Credit and Other Borrowings - Additional HTML 66K
Information (Detail)
16: R42 Commitments and Contingencies - Additional HTML 37K
Information (Detail)
21: R43 Segment Information - Additional Information HTML 29K
(Detail)
24: R44 Summary of Net Revenue by Geographic Location HTML 23K
(Detail)
31: R45 Concentrations - Additional Information (Detail) HTML 29K
13: R46 Income Taxes - Additional Information (Detail) HTML 55K
18: R47 Subsequent Events - Additional Information HTML 54K
(Detail)
59: XML IDEA XML File -- Filing Summary XML 90K
20: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 425K
6: EX-101.INS XBRL Instance -- biol-20130331 XML 711K
8: EX-101.CAL XBRL Calculations -- biol-20130331_cal XML 159K
9: EX-101.DEF XBRL Definitions -- biol-20130331_def XML 678K
10: EX-101.LAB XBRL Labels -- biol-20130331_lab XML 991K
11: EX-101.PRE XBRL Presentations -- biol-20130331_pre XML 767K
7: EX-101.SCH XBRL Schema -- biol-20130331 XSD 144K
56: ZIP XBRL Zipped Folder -- 0001193125-13-214464-xbrl Zip 114K
| EX-31.1 |
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Federico Pignatelli, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of BIOLASE, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: May 10, 2013 | By: | |||
| Federico Pignatelli | ||||
| Chief Executive Officer (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/10/13 | None on these Dates | ||
| For Period end: | 3/31/13 | |||
| List all Filings | ||||